Literature DB >> 8299254

The sensitivity and specificity of reduced CD8 lymphocyte levels in the diagnosis of polymyalgia rheumatica/giant cell arteritis.

M H Arnold1, V M Corrigall, C Pitzalis, G S Panayi.   

Abstract

The aim of this study was to determine whether the sensitivity and specificity of measuring CD8+ T lymphocyte percentages and numbers could be diagnostically useful in the assessment of polymyalgia rheumatica/giant cell arteritis (PMR/GCA). Double immunofluorescence and FACScan analysis were used to identify and quantify the CD3+CD8+ lymphocyte population. The absolute cell numbers were determined by a Coulter Counter. Random disease controls were used for comparison with 30 patients diagnosed as PMR/GCA. Both the percentage of CD3+CD8+ cells (17.4% PMR/GCA group vs 30.5% control) and the absolute numbers of CD8+ lymphocytes (310 cell/ml PMR/GCA vs 723 cells/ml control) were significantly reduced (p < 0.001) in the PMR group. The sensitivity of reduced CD8+ percentages for diagnosis was 73% and the specificity was 85%. Analysis of likelihood ratios showed that CD8+ lymphocyte percentages < 22.15% were five times more likely in patients with PMR/GCA than in controls. Data suggested that reduced CD8+ lymphocyte levels may be useful in the initial clinical assessment of patients with PMR/GCA. Only a larger study can establish whether these parameters should be used as diagnostic criteria.

Entities:  

Mesh:

Year:  1993        PMID: 8299254

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  3 in total

Review 1.  Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis.

Authors:  Ryu Watanabe; Ebru Hosgur; Hui Zhang; Zhenke Wen; Gerald Berry; Jörg J Goronzy; Cornelia M Weyand
Journal:  Joint Bone Spine       Date:  2016-09-20       Impact factor: 4.929

2.  Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.

Authors:  C Salvarani; L Boiardi; P Macchioni; F Rossi; P Tartoni; M Casadei Maldini; R Mancini; E Beltrandi; I Portioli
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

Review 3.  Giant cell arteritis: immune and vascular aging as disease risk factors.

Authors:  Shalini V Mohan; Y Joyce Liao; Jonathan W Kim; Jörg J Goronzy; Cornelia M Weyand
Journal:  Arthritis Res Ther       Date:  2011-08-02       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.